Conventional structural shielding for megavoltage radiotherapy vaults commonly relies on large thicknesses of ordinary concrete. NCRP Report 151 provides dose-based design goals rather than mandating specific materials, yet the practical industry default of thick concrete barriers yields substantial vault footprints—on the order of 150 to 200 m2 per linear accelerator in typical departmental designs. This footprint can limit treatment capacity where floor space is fixed. Recent availability of high-density composite shielding and specialty concretes suggests an opportunity to achieve the same regulatory dose objectives with thinner barriers and smaller vault footprints.
The study aimed to evaluate whether advanced shielding materials could meet the dose-based design goals in NCRP 151 while enabling more compact radiotherapy vault geometries. Specifically, the authors sought to compare conventional concrete against five candidate shielding materials for two common photon beam energies, quantify shielding performance metrics, and project the spatial and clinical implications of implementing optimized materials within a typical multi-vault departmental layout.
The investigation used TOPAS Monte Carlo simulations to model shielding for a 6 MV and an 18 MV linear accelerator (LINAC) vault. Five candidate materials—described in the study as specialty concretes and high-density polymer composites—were compared with ordinary concrete. Simulation outputs included linear attenuation coefficients (μ), tenth-value layers (TVLs), and dose distributions evaluated at regulatory measurement points defined for shielding design.
To illustrate practical impact, the authors modeled a representative 4-vault radiotherapy department and used spatial analyses to quantify changes in vault footprint and the resulting potential for increased clinical capacity when alternative shielding materials were applied.
TOPAS Monte Carlo was employed to simulate photon and secondary radiation transport through the modeled shielding configurations for both 6 MV and 18 MV beams. Key endpoints extracted from the simulations were the linear attenuation coefficient (μ) for each material, derived TVLs, and projected dose rates at regulatory measurement locations. These metrics were then used to calculate the required barrier thicknesses for compliance with the dose-based limits in NCRP 151 and to determine corresponding floor areas for individual vaults.
Compared with conventional concrete, the candidate high-density materials reduced the required vault floor area per linac. For 6 MV beams the projected reductions ranged from 17% to 32%, and for 18 MV beams from 22% to 34%. Two specialty concretes—reported as Steel-magnetite and Datolite-Galena concretes—showed particularly strong space-saving potential for 18 MV operation, with footprint reductions of 28% and 31%, respectively.
Dose projections at regulatory measurement points for those two high-performing concretes were reported as 2.40 × 10^-2 mSv/week for Steel-magnetite and 2.42 × 10^-2 mSv/week for Datolite-Galena. Both values are substantially below the commonly applied public dose limit referenced in NCRP 151 of 0.1 mSv/week, indicating that the thinner barriers composed of these materials can maintain dose compliance while reducing physical barrier thickness.
The simulations produced material-specific μ values and TVLs that underpin these thickness and dose calculations; those computed parameters were used to derive the comparative barrier requirements reported in the results.
Using a modeled four-vault radiotherapy department, the authors translated reduced per-vault footprints into potential increases in effective capacity within the same building envelope. The baseline ordinary concrete requirement corresponded to approximately 165.8 m2 per vault in the modeled scenario. Applying high-density materials that shorten barrier thickness reduced this footprint by the percentages indicated above, which the authors suggest could allow more rooms or more equipment in the same floor area or enable smaller, more cost-efficient new-build footprints.
The TOPAS Monte Carlo study demonstrates that several high-density composite and specialty concrete materials can achieve the dose-based objectives of NCRP 151 with substantially reduced barrier thicknesses and smaller vault footprints. Simulated weekly dose estimates for top-performing materials remained well under the 0.1 mSv/week benchmark used in the design framework. The authors conclude that systematic evaluation of alternative shielding materials may offer practical insights for space-efficient radiotherapy vault design while remaining within established dose-based shielding frameworks.
Where implemented, such material substitutions could support more compact facility designs or improved utilization of existing space, although decisions should be based on full evaluation of material properties, construction considerations, and regulatory review within each jurisdiction.
Monte Carlo simulation; NCRP 151; radiation shielding design; tenth-value layer; vault optimization; TOPAS; high-density composite shielding.